Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 TrialElisa Fontana, Anguraj Sadanandam, David Cunningham et al.|JCO Precision Oncology|2020Cited by 7